74 related articles for article (PubMed ID: 15532990)
1. "One size fits it all": translocation of foreign antigens by Yersinia type III secretion system (TTSS) leads to concomitant CD4 and CD8 T-cell priming.
Rüssmann H; Panthel K
Int J Med Microbiol; 2004 Oct; 294(5):313-7. PubMed ID: 15532990
[TBL] [Abstract][Full Text] [Related]
2. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
3. Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction.
Rüssmann H; Gerdemann U; Igwe EI; Panthel K; Heesemann J; Garbom S; Wolf-Watz H; Geginat G
Infect Immun; 2003 Jun; 71(6):3463-72. PubMed ID: 12761131
[TBL] [Abstract][Full Text] [Related]
4. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
[TBL] [Abstract][Full Text] [Related]
5. Yersinia outer protein E, YopE. A versatile type III effector molecule for cytosolic targeting of heterologous antigens by attenuated Salmonella.
Rüssmann H
Adv Exp Med Biol; 2003; 529():407-13. PubMed ID: 12756799
[TBL] [Abstract][Full Text] [Related]
6. Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.
Rüssmann H; Panthel K; Köhn B; Jellbauer S; Winter SE; Garbom S; Wolf-Watz H; Hoffmann S; Grauling-Halama S; Geginat G
Infect Immun; 2010 Dec; 78(12):5138-50. PubMed ID: 20876292
[TBL] [Abstract][Full Text] [Related]
7. Inverted pathogenicity: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease.
Rüssmann H
Int J Med Microbiol; 2004 Apr; 293(7-8):565-9. PubMed ID: 15149032
[TBL] [Abstract][Full Text] [Related]
8. Yersinia as oral live carrier vaccine: influence of Yersinia outer proteins (Yops) on the T-cell response.
Trülzsch K; Sporleder T; Leibiger R; Rüssmann H; Heesemann J
Int J Med Microbiol; 2008 Jan; 298(1-2):59-67. PubMed ID: 17897880
[TBL] [Abstract][Full Text] [Related]
9. YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection.
González-Juarbe N; Shen H; Bergman MA; Orihuela CJ; Dube PH
PLoS One; 2017; 12(2):e0172314. PubMed ID: 28207901
[TBL] [Abstract][Full Text] [Related]
10. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
[TBL] [Abstract][Full Text] [Related]
11. Coordinate involvement of invasin and Yop proteins in a Yersinia pseudotuberculosis-specific class I-restricted cytotoxic T cell-mediated response.
Falgarone G; Blanchard HS; Virecoulon F; Simonet M; Breban M
J Immunol; 1999 Mar; 162(5):2875-83. PubMed ID: 10072536
[TBL] [Abstract][Full Text] [Related]
12. CCR2+ Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8+ T Cell Response to the Protective YopE69-77 Epitope during Yersinia Infection.
Zhang Y; Tam JW; Mena P; van der Velden AW; Bliska JB
PLoS Pathog; 2015 Oct; 11(10):e1005167. PubMed ID: 26468944
[TBL] [Abstract][Full Text] [Related]
13. Concomitant cytosolic delivery of two immunodominant listerial antigens by Salmonella enterica serovar typhimurium confers superior protection against murine listeriosis.
Igwe EI; Geginat G; Rüssmann H
Infect Immun; 2002 Dec; 70(12):7114-9. PubMed ID: 12438393
[TBL] [Abstract][Full Text] [Related]
14. Yersinia enterocolitica: subversion of adaptive immunity and implications for vaccine development.
Autenrieth SE; Autenrieth IB
Int J Med Microbiol; 2008 Jan; 298(1-2):69-77. PubMed ID: 17702651
[TBL] [Abstract][Full Text] [Related]
15. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
Park JY; Jin DH; Lee CM; Jang MJ; Lee SY; Shin HS; Chung YH; Kim KY; Kim SS; Lee WB; Shin YK; Lee WJ; Park YM; Kim D
J Immunother; 2010 Jun; 33(5):510-22. PubMed ID: 20463596
[TBL] [Abstract][Full Text] [Related]
16. Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors.
Panthel K; Meinel KM; Sevil Domènech VE; Trülzsch K; Rüssmann H
Int J Med Microbiol; 2008 Jan; 298(1-2):99-103. PubMed ID: 17719275
[TBL] [Abstract][Full Text] [Related]
17. Bacterial type III translocation: a unique mechanism for cytosolic display of heterologous antigens by attenuated Salmonella.
Rüssmann H
Int J Med Microbiol; 2003 Apr; 293(1):107-12. PubMed ID: 12755371
[TBL] [Abstract][Full Text] [Related]
18. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
[TBL] [Abstract][Full Text] [Related]
19. Attenuated recombinant Yersinia as live oral vaccine carrier to protect against amoebiasis.
Lotter H; Rüssmann H; Heesemann J; Tannich E
Int J Med Microbiol; 2008 Jan; 298(1-2):79-86. PubMed ID: 17900982
[TBL] [Abstract][Full Text] [Related]
20. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins.
Rüssmann H; Igwe EI; Sauer J; Hardt WD; Bubert A; Geginat G
J Immunol; 2001 Jul; 167(1):357-65. PubMed ID: 11418671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
